Skip to main content

Table 2 Serum concentrations of cytokines from untreated, DMBA Only- and DMBA + ROSI-treated strains

From: Opposing roles for mammary epithelial-specific PPARγ signaling and activation during breast tumour progression

 

PPARγ-WT

PPARγ-MG KO

 

Untreated (n = 5)

DMBA Only (n = 4)

DMBA + ROSI (n = 4)

Untreated (n = 5)

DMBA Only (n = 4)

DMBA + ROSI (n = 4)

Cytokine [signif]

mean ± SD; all values expressed as pg / ml

IL-1α

90.6 ± 56.6

93.9 ± 106.3

48.9 ± 32.9

177.0 ± 206.4

39.8 ± 66.1

36.8 ± 46.0

IL-1β

372.6 ± 105.3

3016.0 ± 5279.0

309.0 ± 74.0

195.4 ± 25.9

870.9 ± 1383.0

116.7 ± 91.1

IL-2

62.8 ± 47.0

42.4 ± 27.9

64.6 ± 80.3

34.9 ± 15.0

24.8 ± 6.1

41.8 ± 32.9

IL-3

6.8 ± 15.2

63.4 ± 111.5

16.0 ± 13.6

12.9 ± 6.6

25.4 ± 40.9

6.8 ± 5.6

IL-4 [gg]

16.1 ± 7.9

16.4 ± 3.2

20.1 ± 10.0

11.8 ± 1.5

10.4 ± 1.2

11.0 ± 1.1

IL-5

40.0 ± 16.3

280.7 ± 454.0

23.2 ± 17.2

ND

77.4 ± 154.8

4.6 ± 9.3

IL-6

18.0 ± 16.4

215.5 ± 387.5

20.7 ± 12.0

5.7 ± 1.5

62.7 ± 106.6

14.5 ± 8.5

IL-9

ND

ND

ND

ND

ND

ND

IL-10 [ggg]

97.3 ± 64.6

163.2 ± 114.2

117.6 ± 48.8

23.5 ± 9.5

39.7 ± 19.9

52.0 ± 20.9

IL-12(p40) [tt]

694.9 ± 299.5

1212.0 ± 302.4

625.3 ± 314.0

554.5 ± 176.1

971.7 ± 306.8

665.1 ± 227.3

IL-12(p70)

ND

ND

ND

ND

ND

ND

IL-13 [g]

654.1 ± 638.6

410.6 ± 437.3

440.6 ± 380.4

95.4 ± 71.7

124.9 ± 33.2

248.0 ± 91.7

IL-17A

32.3 ± 23.8

588.5 ± 1114.0

34.9 ± 19.5

2.1 ± 3.2

150.3 ± 294.5

7.8 ± 12.6

Eotaxin [gg]

1552.0 ± 1593.0

1141.0 ± 890.4

2016.0 ± 743.7

400.4 ± 397.5

620.8 ± 482.6

188.4 ± 163.4

G-CSF

199.6 ± 85.9

1631.0 ± 929.1

3393.0 ± 5274.0

149.1 ± 46.6

564.3 ± 375.5

433.7 ± 121.9

GM-CSF [gggg]

420.2 ± 218.5

384.4 ± 86.8

375.3 ± 94.4

173.0 ± 68.1 *

148.6 ± 47.4

110.1 ± 75.6 Δ

IFN-γ [g]

35.4 ± 38.6

26.6 ± 10.5

23.9 ± 11.3

15.3 ± 6.8

6.8 ± 6.4

9.6 ± 7.0

KC

46.4 ± 62.2

25.3 ± 9.4

41.1 ± 28.2

8.8 ± 1.6

23.1 ± 11.5

14.9 ± 2.4

MCP-1

218.2 ± 132.6

1062.0 ± 1493.0

286.4 ± 156.2

75.8 ± 38.7

190.7 ± 132.6

95.9 ± 17.7

MIP-1α [gg]

67.2 ± 47.2

87.8 ± 38.9

82.5 ± 54.7

45.1 ± 15.2

26.3 ± 8.9

37.1 ± 11.4

MIP-1β

51.9 ± 36.9

525.1 ± 909.0

39.4 ± 13.2

15.2 ± 4.0

185.8 ± 335.4

17.4 ± 15.8

RANTES

31.5 ± 23.1

71.6 ± 76.2

40.7 ± 19.4

37.1 ± 8.5

82.1 ± 97.6

27.2 ± 3.9

TNF-α

1128.0 ± 992.2

19244.0 ± 36869.0

538.0 ± 207.5

272.8 ± 81.9

5763.0 ± 10948.0

363.3 ± 352.8

VEGF

144.6 ± 32.8 (7)

489.7 ± 420.8 (3) **

132.8 ± 33.7 (4) #

254.4 ± 57.0 (8)

167.5 ± 40.9 (4) #

137.3 ± 22.4 (4)

Leptin

22290.0 ± 11260.0 (7)

8040.0 ± 1968.0 (3)

25820.0 ± 18020.0 (4)

13680.0 ± 1899.9 (8)

32140.0 ± 40310.0 (4)

39560.0 ± 44040.0 (4)

PGE Metabolites

560.1 ± 676.7 (5)

76.7 ± 13.7 (4)

93.9 ± 51.6 (4)

141.3 ± 122.2 (4)

335.0 ± 158.5 (3)

229.0 ± 202.7 (3)

  1. Concentrations reported as mean ± standard deviation (SD) and expressed as pg/ml. Except for VEGF, leptin, and PGE metabolites, which were analyzed with separate ELISA kits, all cytokine concentrations were obtained by a multiplex array. *, significantly different from Untreated PPARγ-WT, p < 0.05; **, significantly different from Untreated PPARγ-WT, p < 0.01; #, significantly different from DMBA Only-treated PPARγ-WT, p < 0.05; Δ, significantly different from DMBA + ROSI-treated PPARγ-WT, p < 0.05. g, genotype different, p < 0.05; gg, genotype different, p < 0.01; ggg, genotype different, p < 0.001; gggg, genotype different, p < 0.0001; tt, treatment different p < 0.01; ND, not detectable.